POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection
NCT03400280 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1600
Last updated 2019-06-14
Summary
This Nationwide stepped-wedge cluster randomized trial is designed to evaluate if the implementation of a best practice algorithm for postoperative care results in a decrease in incidence of major complications and death after pancreatic resection as compared to current practice.
Conditions
- Pancreatic Diseases
- Pancreatic Neoplasms
- Pancreatic Cancer
- Pancreatitis
Interventions
- OTHER
-
Best practice algorithm for postoperative care
See arm/group description
Sponsors & Collaborators
-
Dutch Cancer Society
collaborator OTHER -
St. Antonius Hospital
lead OTHER
Principal Investigators
-
Quintus Molenaar, MD, PhD · UMC Utrecht
-
Hjalmar C van Santvoort, MD, PhD · St. Antonius Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-08
- Primary Completion
- 2019-11-09
- Completion
- 2020-02-09
Countries
- Netherlands
Study Locations
More Related Trials
-
Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control
NCT02002806 ·Status: COMPLETED ·Phase: NA
-
Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
NCT00003049 ·Status: COMPLETED ·Phase: PHASE3
-
Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II Trial
NCT03400072 ·Status: UNKNOWN ·Phase: NA
-
The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer
NCT03747588 ·Status: RECRUITING ·Phase: NA
-
Early Recurrence After Surgery for Pancreatic Cancer
NCT07241676 ·Status: ENROLLING_BY_INVITATION
-
Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula
NCT05843877 ·Status: RECRUITING ·Phase: PHASE3
-
PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy
NCT06132087 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer
NCT02184663 ·Status: UNKNOWN ·Phase: NA
-
Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer
NCT03199144 ·Status: WITHDRAWN ·Phase: PHASE2
-
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
NCT04025840 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
NCT07081360 ·Status: RECRUITING ·Phase: PHASE3
-
Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery
NCT03745794 ·Status: COMPLETED ·Phase: PHASE2
-
Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC
NCT06714604 ·Status: RECRUITING ·Phase: PHASE3
-
Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection
NCT01278368 ·Status: COMPLETED ·Phase: NA
-
Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
NCT00014651 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy
NCT03659292 ·Status: UNKNOWN ·Phase: NA
-
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer
NCT04927780 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy
NCT03398291 ·Status: UNKNOWN ·Phase: PHASE3
-
Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic Cancer
NCT03117556 ·Status: WITHDRAWN ·Phase: NA
-
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer
NCT01314027 ·Status: TERMINATED ·Phase: PHASE3
-
Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.
NCT03500068 ·Status: UNKNOWN ·Phase: NA
-
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
NCT06807437 ·Status: RECRUITING ·Phase: PHASE3
-
Improving Pancreatic Cancer Care by the Use of Computational Science and Technology
NCT06055010 ·Status: RECRUITING
-
Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma
NCT00854477 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial
NCT07034703 ·Status: NOT_YET_RECRUITING